Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-17 Sale |
2024-09-19 8:02 pm |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
57,969 | $4.0393 | $234,155 | 5,982,582 (Indirect Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 6:34 pm |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
1,006 | $4 | $4,024 | 6,040,551 (Indirect Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 9:30 pm |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
56,910 | $3.845 | $218,819 | 6,836,490 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
173,467 | $0 | 6,879,949 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
88,601 | $3.06 | 6,879,949 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
639,035 | $0 | 6,879,949 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 9:30 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
173,467 | $0 | 6,836,490 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 9:30 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
448,000 | $0 | 6,836,490 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:33 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
1,249,000 | $0 | 1,249,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
378,033 | $0 | 378,033 (Direct) |
View |
| 2021-06-28 Option Award |
2021-06-30 6:49 pm |
N/A 2031-06-27 |
Kezar Life Sciences Inc. | KZR | Sommadossi Jean-Pierre Director |
26,000 | $0 | 26,000 (Direct) |
View |
Ownership |
2021-02-16 9:59 pm |
N/A N/A |
ABG Acquisition Corp. I | ABGI | Sommadossi Jean-Pierre Director |
0 | $0 | 32,500 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:56 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
640,000 | $0 | 640,000 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:08 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
750,000 | $0 | 5,925,000 (Indirect) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre JPM Partners LLC President, CEO, and Chairman 10% Owner |
0 | $0 | 7,110,000 (Indirect) |
View |
| 2020-06-24 Option Award |
2020-06-26 5:09 pm |
N/A 2030-06-23 |
Kezar Life Sciences Inc. | KZR | Sommadossi Jean-Pierre Director |
8,896 | $0 | 8,896 (Direct) |
View |